Working Today for a Cure Tomorrow




Company Overview

CavoGene LifeSciences is committed to individuals worldwide who are impacted by various neurodegenerative diseases. We are dedicated to the discovery, development and commercialization of novel gene therapies that attenuate memory loss and increase synaptic neuroplasticity, such as Alzheimer’s Disease, Parkinson’s Disease, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis, and Traumatic Brain Injury.

Get in Touch with CavoGene

Want to learn more about CavoGene or have a question about our approach? Use the contact form and let’s start a conversation.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.